So accordingly, Tamil Nadu should procure more doses of the vaccine than states like Bihar, Madhya Pradesh, or Rajasthan despite being less populated.
Bihar’s total population of 12.3 crores is around 60% larger than TN’s 7.6 crores, but only 1.8 crores of its people are 50 years and over, related with the latter’s 2 crores.
States with youthful populations, such as Bihar, also have a slighter proportion of people influenced by co-morbidities.
Also readHere is five News, You Missed If You Spent the Past Week Under a Rock
In Kerala, on the other hand, nearly 30% of the population – roughly 1 crore people – is aged over 50 years with an increased prevalence of diabetes and hypertension, compelling it the state with the increased percentage of people in the preferences category.
The government is formulating to vaccinate about 19.5% of the population forming the 50 plus age group. This will imply about 26.5 crore people, besides the 1 crore health staff and 4 crore diabetics in the below-50 age group.
The proportion of Covid vaccines will, accordingly, be burdened towards states with older populations. Nevertheless, Uttar Pradesh, where only 15% of the people are aged over 50, will still get the largest share of vaccines due to the sheer size of its population.
Maharashtra, West Bengal, and Tamil Nadu, in that injunction, are next in terms of their 50-plus population. Regardless, Kerala tops the list of states by the proportion of population craving vaccination.
Formerly disclosed data from the National Family Health Survey of 2019-20 for 17 states and 5 union territories shows Kerala has the greatest percentage of people with diabetes (25.3%) and hypertension (13.7%).
While 3.6 crore people are competent for preferred vaccination in UP, Maharashtra pursues with 22% of its population, or 2.7 crore people, over the age of 50 years. It also has a high percentage of persons with diabetes and hypertension, which would add to the figures who need to be inoculated.
As the harshness of Covid rises with co-morbidities like hypertension and diabetes, the Centre has agreed to vaccinate even those under the age of 50 years who undergo these conditions.
As the new National Family Health Survey data for major states like UP, MP, Rajasthan, Tamil Nadu, Jharkhand, Punjab, Haryana, and Chhattisgarh is yet to be published, the numbers of diabetics and hypertensives remain unknown.
Also, read:
Here is five News, You Missed If You Spent the Past Week Under a Rock
Pfizer became the first to seek emergency use authorization of its Covid-19 Vaccine in India
Two doses of Oxford vaccine to cost ₹1000, says India’s Serum Institute Chief Adar Poonawalla
